ebook img

Mississippi Pharmacists' Perceptions and Knowledge of ADHD in Children By Anna Crider A thesis ... PDF

57 Pages·2017·0.74 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Mississippi Pharmacists' Perceptions and Knowledge of ADHD in Children By Anna Crider A thesis ...

Mississippi Pharmacists' Perceptions and Knowledge of ADHD in Children By Anna Crider A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College Oxford March 2017 Approved by __________________________________ Advisor: Professor Erin Holmes __________________________________ Reader: Professor John Young __________________________________ Reader: Professor David Gregory © 2017 Anna Crider ALL RIGHTS RESERVED ii ACKNOWLEDGEMENTS I would first like to thank the University of Mississippi School of Pharmacy and the Sally McDonnell Barksdale Honors College. Without their provision of resources and opportunities, this project would have never been possible. Additionally the work, help, and guidance of my advisor, Dr. Erin Holmes, have been immeasurable, and I am grateful for her expertise and knowledge on how to conduct a survey-based research project. I would also like to thank my parents, whose support and love over my life have helped foster my academic curiosity that drove me to conduct this study. ii i ABSTRACT Mississippi Pharmacists’ Perceptions and Knowledge of ADHD in Children Attention-deficit/hyperactivity disorder (ADHD) is a condition that has garnered more attention in the profession of pharmacy in recent years as a result of being more commonly diagnosed in both adult and pediatric populations. With new medications available, pharmacists need to be knowledgeable about how these products may affect patients, especially children. It is crucial to understand pharmacists’ perceptions and knowledge of ADHD and its treatments to optimize their provision of treatment for these patients. Due to the lack of literature dedicated to pharmacists’ knowledge, familiarity, confidence, and perceptions as it relates the condition of ADHD and its treatments, the objectives of this study are to measure community pharmacists’ knowledge of, familiarity with, confidence in counseling for, and perceptions of, ADHD and associated treatments for children. The study objectives were met by employing a descriptive, cross-sectional design. Responses were generated using a self-administered survey that was distributed electronically to Mississippi pharmacists using Qualtrics Survey Software. The results of this study demonstrate that Mississippi pharmacists are generally knowledgeable and comfortable in their role as dispensers of ADHD medications for children and also in counseling patients and families about those medications. However, there still appears to be some need for supplemental education in the form of continuing education or enhanced pharmacy school education to reinforce pharmacists’ knowledge about pharmacological treatments. Pharmacists were less knowledgeable and familiar with iv diagnosis of ADHD and non-pharmacological treatments, which is expected given their practice area. The question to be asked is whether education for pharmacists in these latter areas is necessary, especially if they are not specialists in ADHD. It can be argued that pharmacists would benefit from training in ADHD outside of pharmacological treatments. As the most accessible healthcare professional, pharmacists are likely to be called on by families of patients with ADHD for guidance. Additionally, a collaborative healthcare team approach should be taken between doctor, pharmacist, and therapist to ensure the patient’s ADHD is not only being handled through medication therapy, but through a holistic approach. v TABLE OF CONTENTS LIST OF TABLES……………………………………………………...........................VII LIST OF FIGURES……………………………………………………………………VIII LIST OF SYMBOLS AND ABBREVIATIONS………………......................................IX BACKGROUND……………………………………...………………….…….…………1 METHODS……………………………………………..……………….……………….18 RESULTS………………………………………………..………………………….…...22 DISCUSSION……………………………………….…….………………………….….33 REFERENCES………………………………………………………………….……….40 APPENDICES……………………………………………..……….……………………42 v i List of Tables Table 1: Inattention Symptoms of ADHD……………………………………………..4 Table 2: Hyperactivity and Impulsivity………………………………………………..4 Table 3: Demographic Characteristics………………………………………………...23 Table 4: Pharmacists’ Familiarity with ADHD……………………………………….24 Table 5: Pharmacists’ Knowledge of ADHD…………………………………………26 Table 6: Pharmacists’ Confidence with ADHD………………………………………30 Table 7: Pharmacists’ Perceptions of ADHD…………………………………………31 vi i List of Figures Figure 1: Knowledge Item 1…………………………………………………………… 27 Figure 2: Knowledge Item 4 Responses between BS and PharmD Respondents………28 Figure 3: Knowledge Item 2 Responses between BS and PharmD Respondents………28 Figure 4: Knowledge Item 6 Responses between Independent and Retail Chain Pharmacists………………………………………………………………………….......29 Figure 5: Perception Item 2 Responses between BS and PharmD Respondents……......32 vi ii List of Symbols and Abbreviations ADD: Attention Deficit Disorder ADHD: Attention-deficit/hyperactivity disorder BRIEF: Behavior Rating Inventory of Executive Function BS: Bachelor’s Degree in Pharmacy CBT: Cognitive Behavioral Therapy CDC: Centers for Disease Control CE: Continuing Education CPTs: Continuous Performance Tests CPT-II: Conners’ Continuous Performance Test-II C-2 or C-II: Schedule 2 Controlled Substance DSM: Diagnostic Statistical Manual IRB: Institutional Review Board MS: Master’s Degree in Pharmacy MTA: Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder PADDS: Pediatric Attention Disorders Diagnostic Screener PharmD: Doctor of Pharmacy Degree PhD: Doctor of Philosophy in Pharmacy TOVA: Test of Variables of Attention TTEFs: Target Tests of Executive Functioning ix BACKGROUND Description of the Problem 5.4 million children between the ages of 4 and 17 have been diagnosed with it as of 2007, and 2.7 million are receiving medical therapy due to it. Boys are almost three times more likely to have it than girls, but only 3-7% of school aged children have it (ADHD Data and Statistics in the USA). Attention Deficit Hyperactivity Disorder (ADHD) is an ever-present diagnosis on the rise in the minds of Americans. Over the last two decades, this disorder has grown from unknown to colloquial language throughout various communities, especially academic. In the United States, the western states have almost a ten-fold decrease in ADHD rates compared to the midwestern states; which include some of the highest with Kentucky at a 14.8% ADHD rate (ADHD by the Numbers: Facts, Statistics, and You). Across all disciplines, the Centers for Disease Control (CDC) reports that 11% of American children have ADHD, a 42% increase in just a short eight years from 2003- 2011 (ADHD by the Numbers: Facts, Statistics, and You). According to post-doctoral fellow Meg Reuland who works at the Judge Baker Children’s Center in Boston, Massachusetts, young women are less represented in the diagnosis of ADHD due to the premise that young girls tend to show the inattentive symptoms of ADHD, as opposed to the obvious hyperactive symptoms more typically displayed in boys with ADHD. The inattentive symptoms go unnoticed because it appears that the girl is disinterested and spacey and not symptomatic of ADHD (Interview with Meg Reuland). The disorder is diagnosed far and wide not only across the United States, but also in European countries 1

Description:
electronically to Mississippi pharmacists using Qualtrics Survey Software fellow Meg Reuland who works at the Judge Baker Children's Center in Boston, respondents indicated, “I don't know” for this statement than any other . "Behavior Therapy for Children with ADHD: More Carrot,. Less Stick.
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.